Medscape7h
Compounders Face Deadline to Stop Manufacturing Tirzepatide
The Outsourcing Facilities Association is appealing a ruling that rejected their request for an injunction against the FDA’s ...
Ivim Health Supports the Outsourcing Facilities Association's Appeal of Court Ruling That Further Restricts Access to Compounded GLP-1 Medications
Ivim Health (Ivim), a leading telehealth platform comprised of obesity medicine physicians and nurse practitioners, joins the ...
FDA update could extend Hims & Hers’ compounding timeline, says BofA
BofA analyst Allen Lutz notes that the Food and Drug Administration yesterday provided updated enforcement timelines for semaglutide and ...
Federal judge stops compounded copies of Eli Lilly weight loss, diabetes drugs
A federal judge has effectively ended the ability of compounding pharmacies to make their own copies of Eli Lilly’s weight ...
BioSpace15d
Compounders Sue FDA for Declaring Ozempic, Wegovy Shortage Over
The Outsourcing Facilities Association, a trade group representing compounders, filed a similar lawsuit in October last year ...
US judge denies injunction, restricting copies of Lilly weight-loss drug
A U.S. federal judge has refused to allow compounding pharmacies to keep making copies of Eli Lilly's popular weight-loss and ...
Hims & Hers down as judge denies motion over end to Lilly’s Zepbound shortage
Hims & Hers (NYSE:HIMS) fell ~8% in the premarket Thursday after a federal judge denied a motion filed by a compounding trade ...
Modern Healthcare13d
GLP-1 compounding pharmacies sue FDA over shortage decision
Outsourcing Facilities Association and North American Custom Laboratories allege the FDA removed semaglutide from its ...
Drug compounders sue over weight loss drugs’ removal from FDA shortage list
A trade group representing compounding pharmacies has filed a lawsuit against the Food and Drug Administration (FDA) for removing semaglutide, the active ingredient in Ozempic, from its drug shortage ...
Court denying compounders’ motion positive for Eli Lilly, says Morgan Stanley
Morgan Stanley noted that two compounding groups – the Outsourcing Facilities Association and North American Custom Laboratories – filed a ...
Becker's Hospital Review13d
Compounding pharmacies sue over semaglutide removal from shortage lis
The lawsuit, filed by the Outsourcing Facilities Association , FarmaKeio Custom Compounding and North American Custom Laboratories in the U.S. District Court for the Northern District of Texas, argues ...
Seeking Alpha15d
Drug compounders sue FDA over semaglutide status: report
The Outsourcing Facilities Association, which represents drug compounders, filed the suit in a Texas federal court. The group has alleged the FDA's decision was "capricious and arbitrary," and ...